November 17, 2015

Ajanta is launching its fifth generic product in the U.S. that has received Food and Drug administration approval. 

November 17, 2015

Tagrisso is an EGFR-tyrosine kinase inhibitor, a targeted cancer therapy, designed to inhibit both the activating, sensitizing mutations, and T790M, the genetic mutation responsible for EGFR-TKI treatment resistance in up to approximately two-thirds of cases of EGFRm advanced NSCLC. 

November 17, 2015

Mylan has launched its generic of Axert, a treatment for migraines. 

November 16, 2015

For those patients receiving 90-day supplies of chronic medications, their MPR was 1.4 points higher than the control group as a result of using CVS/pharmacy's ReadyFill program. 

November 16, 2015

The drug is meant to be used on-demand to control bleeding episodes and as a way to reduce their frequency.

November 16, 2015

Mylan has launched two generics — one for diabetes and another for HIV — following final Food and Drug Administration approval. 

November 13, 2015
The drug was granted Fast Track, Breakthrough, Priority Review and Accelerated Approval status by the FDA and has shown an objective response rate of 59% with a median duration of about 12.4 months. 
November 13, 2015

The New York Times is reporting that Manhatta-based pharmacy Irmat, which dispenses products nationwide through the mail is suing UnitedHealth Group’s PBM OptumRx, which plans to drop Irmat at the end of the year. The move follows controversy over Valeant Pharmaceuticals’ involvement with specialty mail-order pharmacy Philidor, which was dropped by Express Scripts, Optum and CVS Caremark in October. (New York Times)

November 13, 2015

Perrigo’s shareholders did not tender a majority of the company’s shares to Mylan by 8 a.m. EST Friday, effectively ending Mylan’s acquisition attempt. 

November 13, 2015

AtlanticLIVE’s event, “The Diabetes Divide,” addressed an issue that affects an estimated 415 million people worldwide. 

November 12, 2015

The moves are part of a strategic move to align efforts for internal improvement, the specialty pharmacy operator said. 

November 12, 2015

LexisNexis’ health care solutions portfolio includes a provider referential database, which blends thousands of data sources, verification techniques and analytics. 

November 12, 2015
With the release of MedHelp's Sugar Sense app for Apple Watch, users can display their glucose readings from their wrists, helping them better understand their condition and stay within their blood glucose targets. 

 

November 12, 2015

Currently, Rite Aid is offering genetic testing for three classes of medications including those used to manage cardiac conditions, cholesterol and attention deficit hyperactivity disorder. 

November 12, 2015

At “Operation Immunization,” students screened seniors in East Harlem to ensure they could receive vaccines that were then administered by registered pharmacists.

November 11, 2015

Usually it takes some time for any individual’s full impact on their company, their profession and their industry to come into focus after that person has moved on.

Such may be the case with Robert I. Thompson, who stepped down Sept. 18 from his position as EVP of pharmacy at Rite Aid.

November 11, 2015

Since Walgreens Boots Alliance announced that it would be acquiring Rite Aid, you’ve likely had some questions about it swirling in your head. Here’s what you need to know. 

November 11, 2015

Health care is transforming, fundamentally and forever. And pharmacy has to change with it. Recognition of that reality has made Rite Aid’s now-former pharmacy leader one of the industry’s leading advocates for a new and broader role for pharmacists.

November 11, 2015

Consider this: 1-in-5 hospital patients end up back in the hospital within 30 days of their discharge. And the biggest factors pulling them back all have to do with medications — either through medication errors, nonadherence or adverse drug events.

November 11, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, regulations, technology, automation and medication synchronization, in this multi-page report.

November 11, 2015

The combination of Cotellic with Zelboraf helps patients with previously untreated BRAF V600 mutation-positive advanced melanoma live a median of one year (12.3 months) without their disease worsening, compared to 7.2 months with Zelboraf alone.

November 11, 2015

Valeant Pharmaceuticals’ decision to raise the prices on a handful of drugs it has acquired over the past few years has led federal lawmakers and the Department of Justice to demand that the company explain its pricing policy.

November 11, 2015

A new drug has been approved that, in conjunction with vemurafenib, is meant to treat metastatic melanoma that can't be removed through surgery with a certain gene mutation. 

November 11, 2015

Usually it takes some time for any individual’s full impact on their company, their profession and their industry to come into focus after that person has moved on.

Such may be the case with Robert I. Thompson, who stepped down Sept. 18 from his position as EVP of pharmacy at Rite Aid.